Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

7 Sept 2015

Abstract excerpt

// Elizabeth S. Gabitzsch 1 , Kwong Yok Tsang 2 , Claudia Palena 2 , Justin M. David 2 , Massimo Fantini 2 , Anna Kwilas 2 , Adrian E. Rice 1 , Yvette Latchman 1 , James W. Hodge 2 , James L. Gulley 3 , Ravi A. Madan 3 , Christopher R. Heery 2 , Joseph P. Balint Jr. 1 , Frank R. Jones 1, * , Jeffrey Schlom 2, * 1 Etubics Corporation, Seattle, WA, USA 2 Laboratory of Tumor Immunology and Biology, Center for Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26374823
DOI: 10.18632/oncotarget.5181

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeuticPMID 26374823Read ↗

Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based ImmunotherapySemantic proximity Read ↗

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read ↗

Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and VaccinesSemantic proximity Read ↗

Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approachesSemantic proximity Read ↗

Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunitiesSemantic proximity Read ↗

Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectorsSemantic proximity Read ↗

Current Developments In Adenovirus-Based Cancer Gene TherapySemantic proximity Read ↗

Rekindling cancer vaccines.Semantic proximity Read ↗

Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subsetSemantic proximity Read ↗

Dendritic cell targeting in lymph nodes with engineered modular adapters improves HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21Semantic proximity Read ↗

Dendritic cells expressing a combined PADRE/MUC4-derived polyepitope DNA vaccine induce multiple cytotoxic T-cell responses.Semantic proximity Read ↗

Adenoviruses as gene/vaccine delivery vectors: promises and pitfallsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.